Summary & Overview
CPT 77427: Radiation Treatment Management for Five Sessions
CPT code 77427 is a key billing code in radiation oncology, representing the management of a patient undergoing five radiation therapy treatments. This code is widely used across the United States in outpatient hospital settings, reflecting the ongoing clinical oversight required during a course of radiation therapy. The code is recognized by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, making it relevant for providers and health systems seeking to understand reimbursement and policy trends.
This publication provides a comprehensive overview of 77427, including payer coverage, clinical context, and related billing practices. Readers will gain insight into the typical use of this code, associated modifiers, and relevant taxonomies for radiation oncology and nuclear medicine physicians. The summary also highlights common ICD-10 diagnoses linked to radiation treatment management, such as malignant neoplasms of the breast, prostate, lung, colon, and brain. Additionally, related CPT codes for alternative radiation therapy management scenarios are discussed, offering a broader perspective on coding options within radiation oncology.
The article is designed to inform healthcare professionals, administrators, and policy analysts about the national landscape for radiation treatment management billing, including benchmarks and recent policy updates.
CPT Code Overview
CPT code 77427 represents radiation treatment management for five treatments. This code is used in the field of radiation oncology to document and bill for the professional management of a patient undergoing a series of radiation therapy sessions. The typical site of service for this procedure is an outpatient hospital setting, designated as Place of Service 22. Radiation treatment management involves overseeing the patient's care during the course of therapy, including assessment of treatment response, management of side effects, and coordination of care.
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with a malignant neoplasm, such as breast, prostate, lung, colon, or brain cancer, is referred to the outpatient hospital for radiation therapy. The clinical workflow involves the patient receiving a series of radiation treatments, typically five sessions, managed by a radiation oncology physician. During these sessions, the provider oversees the treatment plan, monitors the patient's response, evaluates side effects, and adjusts therapy as needed. The management of these five treatments is reported using CPT code 77427.
Coding Specifications
-
Modifiers:
-
Modifier
26: Used to report the professional component, indicating the physician's management and oversight of the radiation treatment. -
Modifier
TC: Used to report the technical component, representing the facility's provision of equipment, supplies, and technical staff for the treatment. -
Modifier
52: Indicates reduced services when the full scope of the procedure is not performed. -
Modifier
53: Used when the procedure is discontinued due to unforeseen circumstances.
-
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
2085R0001X | Radiation Oncology Physician |
2085N0700X | Nuclear Medicine Physician |
2085B0100X | Body Imaging Physician |
These taxonomies represent providers specializing in radiation oncology, nuclear medicine, and body imaging, all of whom may be involved in radiation treatment management.
Related Diagnoses
-
C50.911: Malignant neoplasm of unspecified site of right female breast- Relevant for patients undergoing radiation treatment management for breast cancer.
-
C61: Malignant neoplasm of prostate- Used for patients receiving radiation therapy for prostate cancer.
-
C34.90: Malignant neoplasm of unspecified part of unspecified bronchus or lung- Indicates lung cancer cases managed with radiation therapy.
-
C18.9: Malignant neoplasm of colon, unspecified- Applied when radiation treatment is provided for colon cancer.
-
C71.9: Malignant neoplasm of brain, unspecified- Used for patients with brain cancer receiving radiation treatment management.
Each diagnosis code represents a type of cancer commonly managed with radiation therapy, aligning with the clinical indications for CPT code 77427.
Related CPT Codes
-
77431: Radiation therapy management with complete course of therapy consisting of 1 or 2 fractions only.- Used when the patient receives only 1 or 2 radiation treatments, rather than the 5 treatments covered by
77427. This code is an alternative for shorter courses of therapy.
- Used when the patient receives only 1 or 2 radiation treatments, rather than the 5 treatments covered by
-
77432: Stereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of 1 session).- Used for stereotactic radiation therapy specifically for cranial lesions, typically in a single session. This code is an alternative to
77427when stereotactic techniques are used for cranial cases.
- Used for stereotactic radiation therapy specifically for cranial lesions, typically in a single session. This code is an alternative to
These codes are related to 77427 as alternatives for different treatment regimens or specialized techniques. They are not commonly used together but may be selected based on the clinical scenario.
National Reimbursement Benchmarks
Nationally, Medicare's mean rate for CPT code 77427 is $200.63, which is notably lower than the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, Aetna) average commercial mean rate of $260.43. Among individual commercial payers, Cigna has the highest mean rate at $302.30, while Aetna is the lowest at $230.02.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare exhibits the tightest range ($15.00), indicating relatively consistent reimbursement. Cigna shows the widest dispersion ($170.00), reflecting greater variability in rates. Blue Cross Blue Shield and UnitedHealth Group also display substantial ranges ($111.00 and $150.00, respectively), while Aetna and BUCA have moderate spreads ($121.00 and $117.00).
The table and chart below present the full breakdown of national benchmarks for CPT code 77427 by payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.